Loading live market data…

IDEXX Laboratories, Inc.

NASDAQ:IDXX

$540.68 USD

-$23.53 (-4.17%)

Volume
780.14K
Average Volume
657.72K
Market Capitalization
$42.65B
P/E Ratio
39.55
Dividend Yield
0.00%
Price Target
$775.00
Year High
$769.98
Year Low
$506.91
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.12

Industry, Sector & symbol

Stock Exchange NASDAQ
CEO Jonathan J. Mazelsky
Industry Medical - Diagnostics & Research
Sector Healthcare
Current Symbol IDXX
CUSIP 45168D104
CIK 0000874716
Web https://www.idexx.com
Phone 207 556 0300
Currency USD
Employees 11000
Country US

Liquidity

Debt-to-Equity Ratio 0.71
Payout Ratio 0.00
Current Ratio 1.12
Quick Ratio 0.82
Cash Ratio 0.15

Sales & Book Value

Annual Sales $4.3B
Price / Sales 9.59
Cash Flow 13.48
Price / Cash Flow 39.50
Price / Book 27.83

Price Target and Rating

Average Stock Price Forecast $775.00
High Stock Price Forecast $800.00
Low Stock Price Forecast $640.00
Forecast Upside/Downside -30.23%
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 22 Analysts

Profitability

EPS (Most Recent Fiscal Year) $13.08
Trailing P/E Ratio 39.55
PEG Ratio 1.56
P/E Growth 1.56
Net Income $1.06B
Net Margin 24.63%
Pretax Margin 30.80%
Return on Equity 70.87%
Return on Assets 32.35%

Financials Score

AltmanZ Score 20.10
Piotroski Score 8.00
Working Capital 154.22M
Total Assets 3.39B
Ebit 1.41B
Market Cap 44.51B
Total Liabilities 1.83B

Poll Results

About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinaria ... ns. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending

2026-07-14 10:45:22

Data centers receive sharp criticism for their high water usage, but the impact on the broader water industry and for investors is also about infrastructure bottlenecks, regulation, and emerging technologies, among other things. Utilities companies must navigate significant changes when hyperscalers enter their territory—in some cases, a new data center operator may immediately become one of the largest customers in the region.

Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H

2026-07-14 08:41:07

ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.

ALC vs. IDXX: Which Stock Is the Better Value Option?

2026-07-07 12:41:10

Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

2026-07-01 16:00:00

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2026 Earnings Snapshot through a link on the IDEXX websi.

Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term

2026-06-30 10:46:22

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Is the Options Market Predicting a Spike in IDEXX Laboratories Stock?

2026-06-29 11:06:05

Investors need to pay close attention to IDXX stock based on the movements in the options market lately.

IDEXX Laboratories Inc (IDXX) Stock Down 4.7% -- Now Undervalued? GF Score: 96/100

2026-06-17 18:11:00

On June 17, 2026, IDEXX Laboratories Inc (IDXX) shares fell 4.7% to $546.09. The stock's current price is within a 52-week range of $506.91 to $769.98, reflecti

Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock

2026-06-11 10:52:04

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Frequently Asked Questions

What is the current IDEXX Laboratories, Inc. (IDXX) stock price?

IDEXX Laboratories, Inc.(NASDAQ:IDXX) stock price is $540.68 in the last trading session. During the trading session, IDXX stock reached the peak price of $769.98 while $506.91 was the lowest point it dropped to. The percentage change in IDXX stock occurred in the recent session was --4.17% while the dollar amount for the price change in IDXX stock was -$-23.53.

IDXX's industry and sector of operation?

The NASDAQ listed IDXX is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of IDXX?

Andrew Emerson | Executive Vice President, Chief Financial Officer & Treasurer
Amit Gupta | Senior VP, Chief Digital & Information Officer
Martin Smith | Executive Vice President of Global Operations and R&D
Jonathan J. Mazelsky | Executive Chairman
Michael J. Lane | Executive Vice President and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology

How many employees does IDXX have?

Number of IDXX employees currently stands at 11000. IDXX operates from One IDEXX Drive, Westbrook, ME 04092, US.

Link for IDXX official website?

Official Website of IDXX is: https://www.idexx.com

How do I contact IDXX?

IDXX could be contacted at phone #207 556 0300 and can also be accessed through its website. IDXX operates from One IDEXX Drive, Westbrook, ME 04092, US.

How many shares of IDXX are traded daily?

The average number of IDXX shares traded daily for last 3 months was 657.72K.

What is the market cap of IDXX currently?

The market value of IDXX currently stands at $42.65B with its latest stock price at $540.68